A nurse led psychosocial intervention with peer support to reduce psychosocial needs in women with gynaecological cancer
Not Applicable
Completed
- Conditions
- gynaecological cancerCancer - Womb (Uterine or endometrial cancer)Cancer - Ovarian and primary peritonealCancer - Cervical (cervix)
- Registration Number
- ACTRN12609000312246
- Lead Sponsor
- Prof Penelope Schofield
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 10
Inclusion Criteria
a confirmed diagnosis of gynaecological cancer; scheduled to receive radiotherapy with curative intent to the pelvis; aged 18 years or older; able to read and write English; and give informed consent.
Exclusion Criteria
Exclusion criteria are a severe psychiatric or cognitive disorder; treatment with palliative intent; or previous treatment with radiotherapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Psychological distress (HADS - Hospital Anxiety & Depression Scale).[Pre-treatment, first day of treatment, 4 wks post-treatment, 6 & 12 months post-treatment.]
- Secondary Outcome Measures
Name Time Method informational and psychological supportive care needs (Supportive Care Needs Survey (SCNS)).[Pre-treatment, 4 wks post-treatment.];MSAS-SF (Memorial symptom Assessment scale - short form)[Pre-treatment, 4 wks post-treatment.];SVQ - sexual function and vaginal changes questionnaire.[Pre-treatment, 6 & 12 months post-treatment.];CaTS - Cancer Treatment Survey.[Pre-treatment, first day of treatment, 4-wks post-treatment.];Adherence Questionnaire - Patient self-report adherence to recommendations for dilator use are assessed using this custom-made scale. [4-wks, 6 & 12 months post-treatment. ]
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does nurse-led psychosocial intervention with peer support modulate cortisol levels and CRP in gynecological cancer patients undergoing radiotherapy?
What is the comparative effectiveness of nurse-led psychosocial programs versus standard care in reducing distress and improving quality of life in women with uterine, ovarian, or cervical cancer?
Which biomarkers correlate with psychosocial distress in endometrial, ovarian, and cervical cancer patients receiving curative radiotherapy?
What adverse events are reported in nurse-led peer support interventions for gynecological cancer patients and how are they managed?
How do nurse-led psychosocial interventions compare to other non-pharmacological therapies in addressing unmet needs during gynecological cancer radiotherapy?